FINWIRES · TerminalLIVE
FINWIRES

Suncorp Places Main Catastrophe Program for Fiscal Year 2027

By

Suncorp Group (ASX:SUN) placed its main catastrophe program for the fiscal year 2027, which maintains the maximum event retention of AU$350 million for a first and second large event, covering the home, motor, and commercial property portfolios across Australia and New Zealand, according to a Friday Australian bourse filing.

Suncorp's five-year aggregate reinsurance arrangement began on June 30, with the aggregate cover providing AU$800 million of protection annually, up to AU$2.4 billion in total, over the five years. The fiscal 2027 attachment point for the aggregate cover is AU$1.85 billion.

The catastrophe cover protects losses between AU$500 million and AU$6.4 billion, and includes one full prepaid reinstatement. Group dropdown covers for losses between AU$350 million and AU$500 million were purchased in relation to the third and fourth events.

The firm's total reinsurance costs in fiscal year 2027 are expected to be higher than in fiscal year 2026, reflecting the inclusion of the aggregate reinsurance cover and exposure growth, partly offset by improved pricing in the main catastrophe program.

Its total investment income for fiscal year 2026 is expected to be between AU$750 million and AU$800 million, compared with AU$1.23 billion in fiscal year 2025.

Chief Executive Steve Johnston will return from medical leave effective July 6, while acting CEO Jeremy Robson will return to his role as Chief Financial Officer.

Related Articles

Asia

SSY Gets China Production Nod for Methocarbamol Tablets, Registers Phloroglucinol Dihydrate

SSY Group (HKG:2005) obtained production and registration approval for Methocarbamol Tablets and registration approval for Phloroglucinol Dihydrate from China's National Medical Products Administration, according to a Thursday Hong Kong bourse filing.The approval for Methocarbamol Tablets came as the drug passed the regulator's consistency evaluation.Methocarbamol Tablets are muscle relaxants mainly used to treat joint and muscle sprains, lumbar muscle strain, and sciatica.Phloroglucinol Dihydrate is used to treat acute spasmodic pain associated with digestive, biliary, urinary, and gynecological conditions.Shares of the firm were up nearly 5% in late morning trade on Thursday.

HKG:2005
Asia

Bellavista Resources Starts Drilling at Canada, Western Australia Projects; Shares Gain 3%

Bellavista Resources (ASX:BVR) started drilling the Pickle Crow gold project in Canada and at its Brumby project in Western Australia, according to a Thursday filing with the Australian bourse.Initial drilling at Pickle Crow for the remainder of the year will assess the open-pit potential on the existing mineral resource of 2.7 million ounces at 7.2 grams per tonne grade of gold, before moving to additional near-surface regional targets in early 2027.At Brumby, the company will assess mineralization continuity for a potential future resource definition drilling program, alongside column leach test work.Bellavista Resources shares gained 3% in recent Thursday trade.

ASX:BVR
Asia

Binastra Unit Bags MYR491 Million Data Center Development Deal

Binastra (KLSE: BNASTRA) unit Binastra Builders secured a 491.2 million ringgit turnkey contract to develop a seven-story data center in Kuala Lumpur, according to a Wednesday Bursa Malaysia filing.The contract, awarded by Exsim Sri Permai, covers the design, construction, testing, commissioning, maintenance and guarantee works, including foundation, substructure, main building and infrastructure works.The project, which also includes a guardhouse, refuse room and electrical substation, is scheduled to begin on July 1 and be completed within 18 months.

KLSE:BNASTRA